MAPT and Alzheimer disease: A definitive AD diagnosis relies on post-mortem histological confirmation, but imaging and analyses of cerebrospinal fluid (CSF) Aβ1–42 (Aβ42), total Tau (T-tau) and phosphorylated Tau (P-tau) have transformed the field by enabling early and reliable ante-mortem AD diagnosis.